Furthermore, we validated HMGCS2 as a tumor suppressor in renal clear cell carcinoma (ccRCC) through in vitro experiments, demonstrating that the loss of HMGCS2 leads to malignant cellular behavior in ccRCC. The gene discussed is HMGCS2; the disease is neoplasm.